Chabiotech Co.,Ltd. (KOSDAQ:085660)
10,680
-210 (-1.93%)
Jun 16, 2025, 3:30 PM KST
Chabiotech Revenue
Chabiotech had revenue of 304.14B KRW in the quarter ending March 31, 2025, with 30.87% growth. This brings the company's revenue in the last twelve months to 1.12T, up 17.57% year-over-year. In the year 2024, Chabiotech had annual revenue of 1.05T with 9.55% growth.
Revenue (ttm)
1,116.79B
Revenue Growth
+17.57%
P/S Ratio
0.54
Revenue / Employee
3.82B
Employees
292
Market Cap
597.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,045.05B | 91.10B | 9.55% |
Dec 31, 2023 | 953.95B | 109.37B | 12.95% |
Dec 31, 2022 | 844.58B | 117.11B | 16.10% |
Dec 31, 2021 | 727.48B | 62.76B | 9.44% |
Dec 31, 2020 | 664.72B | 130.11B | 24.34% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
Peptron | 4.30B |